Immunoscore: a novel prognostic tool. Association with clinical outcome, response to treatment and survival in several malignancies.

Ros-Martínez, Silverio; Navas-Carrillo, Diana; Alonso-Romero, José Luis; Orenes-Piñero, Esteban

Ros-Martínez, Silverio; Navas-Carrillo, Diana; Alonso-Romero, José Luis; Orenes-Piñero, Esteban.

Afiliação

Ros-Martínez S; Department of Oncology, Hospital Clínico Universitario Virgen de la Arrixaca, (IMIB-Arrixaca), Universidad de Murcia, Murcia, Spain.
Navas-Carrillo D; Department of Surgery, Hospital La Vega, Murcia, Spain.
Alonso-Romero JL; Department of Oncology, Hospital Clínico Universitario Virgen de la Arrixaca, (IMIB-Arrixaca), Universidad de Murcia, Murcia, Spain.
Orenes-Piñero E; Department of Biochemistry and Molecular Biology-A, University of Murcia, Murcia, Spain.

Crit Rev Clin Lab Sci ; 57(7): 432-443, 2020 11.

Article em En | MEDLINE | ID: mdl-32175789

Assuntos

Estadiamento de Neoplasias/métodos; Neoplasias/classificação; Linfócitos T/imunologia; Humanos; Neoplasias/imunologia; Prognóstico; Linfócitos T/metabolismo; Microambiente Tumoral

Palavras-chave

Immunoscore; T-lymphocyte CD3+; T-lymphocyte CD8+; cancer; prognosis; survival; treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Estadiamento de Neoplasias / Neoplasias Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google